Skip to content

Low Field Magnetic Stimulation Treatment for Bipolar Depression

Low Field Magnetic Stimulation in Bipolar Depression

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00217217
Enrollment
13
Registered
2005-09-22
Start date
2004-09-30
Completion date
2012-01-31
Last updated
2012-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Depression, Bipolar Disorder, Depression

Keywords

non-pharmaceutical, alternative, imaging, magnetic resonance imaging, low field magnetic stimulation, bipolar disorder, depression, bipolar depression

Brief summary

Individuals with bipolar depression who had a particular kind of brain imaging reported improved mood after the imaging. This effect may be linked to the changing magnetic fields used during these magnetic resonance imaging studies. The current studies are designed to further explore the important parameters of this effect and to clarify the degree and duration of the mood effects.

Detailed description

An initial study using proton echo-planar magnetic resonance spectroscopic imaging (EP-MRSI) in bipolar depressed individuals was associated with reports of improved mood. These studies employed oscillating magnetic fields similar to those used in functional MRI (fMRI), but which differ from the usual fMRI scan in field direction, waveform frequency, and strength. As the abbreviation EP-MRSI is used to describe several relatively common MR sequences, the specific potential clinical procedure being used is referred to as low field magnetic stimulation or LFMS. Following these initial results, investigators are conducting studies to determine the critical variables in both subjects and treatment for optimal response. Studies are also underway to characterize the response of specific depression symptoms, the degree of response, and the duration of response.

Interventions

DEVICEEcho-Planar Magnetic Resonance Imaging (EP-MRSI)

variable-setting low-frequency MRI

Sponsors

Stanley Medical Research Institute
CollaboratorOTHER
Mclean Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Primary diagnosis of bipolar disorder. * Current depression.

Exclusion criteria

* Contraindication for MRI due to metal in eyes/head * Claustrophobia. * Inability to lie flat. * History of brain injury.

Design outcomes

Primary

MeasureTime frame
Positive and Negative Affect Scalepre/post-treatment

Secondary

MeasureTime frame
Visual-Analog Scalespre/post-treatment
Montgomery Asberg Depression Rating Scale (MADRS)pre-treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026